Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab

Study ID: NCT06816927
Start Date: 2025-06-01
End Date: 2031-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

92

Intervention / Treatment

Nivolumab

Relatylimab

TMZ

Radiation Therapy

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Pelacarsen Roll-over Extension Program

Study ID: NCT06875973
Start Date: 2025-05-20
End Date: 2028-01-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

PELACARSEN (TQJ230)

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation

Study ID: NCT06407427
Start Date: 2025-05
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

App for in-bed conditioning exercises

Usual care

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of IQ-007

Study ID: NCT06899230
Start Date: 2025-04-24
End Date: 2025-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

72

Intervention / Treatment

iQ-007

Placebo

Sponsor

iQure Australia Pty Ltd

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections

Study ID: NCT06800248
Start Date: 2025-08
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

315

Intervention / Treatment

emodepside (BAY 44-4400)

Mebendazole 100 MG

similar placebo to mebendazole

matching placebo of emodepside

Sponsor

Swiss Tropical & Public Health Institute

Source: clinicaltrials.gov

Share:
Add to list

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Study ID: NCT05467748
Start Date: 2025-04-28
End Date: 2029-04-27
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Tulimimetostat

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

Study ID: NCT06414057
Start Date: 2025-04-30
End Date: 2025-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Offering opportunistic HPV vaccine during routine sexual health clinic visits

Sponsor

University of Edinburgh

Source: clinicaltrials.gov

Share:
Add to list

Radiopharmaceutical Treatment of Advanced Kidney Cancer

Study ID: NCT06783348
Start Date: 2025-10-30
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

177Lu-PSMA-617

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Source: clinicaltrials.gov

Share:
Add to list

Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough

Study ID: NCT06858748
Start Date: 2025-06
End Date: 2028-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

240

Intervention / Treatment

Observational

Sponsor

McMaster University

Source: clinicaltrials.gov

Share:
Add to list

THE THERAPEUTIC EFFECT OF CURCUMIN IN NANOGELS COMPARED TO 0.1% FAO IN THE MANAGEMENT OF ORAL LICHEN PLANUS

Study ID: NCT06932848
Start Date: 2025-06-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Curcumin in Nanogels

0.1% Fluocinolone Acetonide Oral Paste

Sponsor

Chulalongkorn University

Source: clinicaltrials.gov

Share:
Add to list